Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-08-13

FDA Approved: ZESTORETIC — Supplemental Application (Almatica Pharma Inc.)

View source ↗

Summary

FDA supplemental approval for ZESTORETIC (lisinopril and hydrochlorothiazide) submitted by Almatica Pharma Inc. to update the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)

Snippet

SUPPL AP for ZESTORETIC (LISINOPRIL AND HYDROCHLOROTHIAZIDE)